KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Debt (2016 - 2025)

Amgen has reported Total Debt over the past 17 years, most recently at $54.6 billion for Q4 2025.

  • Quarterly results put Total Debt at $54.6 billion for Q4 2025, down 9.14% from a year ago — trailing twelve months through Dec 2025 was $54.6 billion (down 9.14% YoY), and the annual figure for FY2025 was $54.6 billion, down 9.14%.
  • Total Debt for Q4 2025 was $54.6 billion at Amgen, roughly flat from $54.6 billion in the prior quarter.
  • Over the last five years, Total Debt for AMGN hit a ceiling of $64.6 billion in Q4 2023 and a floor of $32.7 billion in Q1 2021.
  • Median Total Debt over the past 5 years was $55.4 billion (2025), compared with a mean of $50.3 billion.
  • Biggest five-year swings in Total Debt: surged 68.51% in 2023 and later fell 10.37% in 2025.
  • Amgen's Total Debt stood at $33.3 billion in 2021, then grew by 16.92% to $38.9 billion in 2022, then surged by 65.91% to $64.6 billion in 2023, then dropped by 6.99% to $60.1 billion in 2024, then decreased by 9.14% to $54.6 billion in 2025.
  • The last three reported values for Total Debt were $54.6 billion (Q4 2025), $54.6 billion (Q3 2025), and $56.2 billion (Q2 2025) per Business Quant data.